Allan R. Albig, Ph.D - Publications

Indiana State University, Evansville, IN, United States 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 LaFoya B, Munroe JA, Albig AR. A comparison of resveratrol and other polyphenolic compounds on Notch activation and endothelial cell activity. Plos One. 14: e0210607. PMID 30653610 DOI: 10.1371/journal.pone.0210607  0.36
2018 LaFoya B, Munroe JA, Pu X, Albig AR. Src kinase phosphorylates Notch1 to inhibit MAML binding. Scientific Reports. 8: 15515. PMID 30341382 DOI: 10.1038/s41598-018-33920-y  0.36
2018 LaFoya B, Munroe JA, Miyamoto A, Detweiler MA, Crow JJ, Gazdik T, Albig AR. Beyond the Matrix: The Many Non-ECM Ligands for Integrins. International Journal of Molecular Sciences. 19. PMID 29393909 DOI: 10.3390/ijms19020449  0.36
2016 LaFoya B, Munroe JA, Mia MM, Detweiler MA, Crow JJ, Wood T, Roth S, Sharma B, Albig AR. Notch: A multi-functional integrating system of microenvironmental signals. Developmental Biology. PMID 27565024 DOI: 10.1016/j.ydbio.2016.08.023  0.36
2016 Deford P, Brown K, Richards RL, King A, Newburn K, Westover K, Albig AR. MAGP2 controls Notch via interactions with RGD binding integrins: Identification of a Novel ECM - Integrin - Notch Signaling Axis. Experimental Cell Research. PMID 26808411 DOI: 10.1016/j.yexcr.2016.01.011  1
2015 Pandey R, Botros MA, Nacev BA, Albig AR. Cyclosporin a disrupts notch signaling and vascular lumen maintenance. Plos One. 10: e0119279. PMID 25775018 DOI: 10.1371/journal.pone.0119279  1
2013 Lehman JA, Hauck PM, Gendron JM, Batuello CN, Eitel JA, Albig A, Kadakia MP, Mayo LD. Serdemetan antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes. Plos One. 8: e74741. PMID 24040331 DOI: 10.1371/journal.pone.0074741  1
2013 Sharma B, Ramus MD, Kirkwood CT, Sperry EE, Chu PH, Kao WW, Albig AR. Lumican exhibits anti-angiogenic activity in a context specific manner. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 263-71. PMID 23775523 DOI: 10.1007/s12307-013-0134-2  1
2013 Sharma B, Albig AR. Matrix Gla protein reinforces angiogenic resolution. Microvascular Research. 85: 24-33. PMID 23110920 DOI: 10.1016/j.mvr.2012.10.005  1
2010 Williams KE, Fulford LA, Albig AR. Lumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 4: 115-26. PMID 21505566 DOI: 10.1007/s12307-010-0056-1  1
2010 Brown LJ, Alawoki M, Crawford ME, Reida T, Sears A, Torma T, Albig AR. Lipocalin-7 is a matricellular regulator of angiogenesis. Plos One. 5: e13905. PMID 21085487 DOI: 10.1371/journal.pone.0013905  1
2008 Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 29: 2243-51. PMID 18713838 DOI: 10.1093/carcin/bgn199  1
2008 Albig AR, Becenti DJ, Roy TG, Schiemann WP. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvascular Research. 76: 7-14. PMID 18417156 DOI: 10.1016/j.mvr.2008.01.001  1
2007 Albig AR, Roy TG, Becenti DJ, Schiemann WP. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis. 10: 197-216. PMID 17632767 DOI: 10.1007/s10456-007-9075-z  1
2006 Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Research. 66: 2621-9. PMID 16510581 DOI: 10.1158/0008-5472.CAN-04-4096  1
2005 Albig AR, Schiemann WP. Fibulin-5 function during tumorigenesis. Future Oncology (London, England). 1: 23-35. PMID 16555973 DOI: 10.1517/14796694.1.1.23  1
2005 Albig AR, Schiemann WP. Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Molecular Biology of the Cell. 16: 609-25. PMID 15548600 DOI: 10.1091/mbc.E04-06-0479  1
2004 Albig AR, Schiemann WP. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. Dna and Cell Biology. 23: 367-79. PMID 15231070 DOI: 10.1089/104454904323145254  1
2001 Albig AR, Decker CJ. The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Molecular Biology of the Cell. 12: 3428-38. PMID 11694578  1
Show low-probability matches.